Successful restoration of checkpoint inhibitors efficacy after allogeneic hematopoietic cell transplant for classic Hodgkin lymphoma patients
Article in Seminars in Oncology (May 2023)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Immune Checkpoint Inhibitors in Hodgkin Lymphoma and Non-Hodgkin Lymphoma
Book chapter (March 2023)
Immune-related adverse events induced by programmed death protein-1 inhibitors from the perspective of lymphoma immunotherapy
Article in World Journal of Clinical Cases (March 2023)